Found 20 Enz. Inhib. hit(s) with all data for entry = 9553 TargetDeoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial(Homo sapiens (Human))
CV6 Therapeutics (NI)
US Patent
CV6 Therapeutics (NI)
US Patent
Affinity DataIC50: 800nMAssay Description:The assay employs a DNA polymerase-based approach utilizing an oligonucleotide template with 3 distinct regions: a 3′ primer binding region, a ...More data for this Ligand-Target Pair
TargetDeoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial(Homo sapiens (Human))
CV6 Therapeutics (NI)
US Patent
CV6 Therapeutics (NI)
US Patent
Affinity DataIC50: 800nMAssay Description:The assay employs a DNA polymerase-based approach utilizing an oligonucleotide template with 3 distinct regions: a 3′ primer binding region, a ...More data for this Ligand-Target Pair
TargetDeoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial(Homo sapiens (Human))
CV6 Therapeutics (NI)
US Patent
CV6 Therapeutics (NI)
US Patent
Affinity DataIC50: 1.25E+3nMAssay Description:The assay employs a DNA polymerase-based approach utilizing an oligonucleotide template with 3 distinct regions: a 3′ primer binding region, a ...More data for this Ligand-Target Pair
TargetDeoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial(Homo sapiens (Human))
CV6 Therapeutics (NI)
US Patent
CV6 Therapeutics (NI)
US Patent
Affinity DataIC50: 1.30E+3nMAssay Description:The assay employs a DNA polymerase-based approach utilizing an oligonucleotide template with 3 distinct regions: a 3′ primer binding region, a ...More data for this Ligand-Target Pair
TargetDeoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial(Homo sapiens (Human))
CV6 Therapeutics (NI)
US Patent
CV6 Therapeutics (NI)
US Patent
Affinity DataIC50: 2.00E+3nMAssay Description:The assay employs a DNA polymerase-based approach utilizing an oligonucleotide template with 3 distinct regions: a 3′ primer binding region, a ...More data for this Ligand-Target Pair
TargetDeoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial(Homo sapiens (Human))
CV6 Therapeutics (NI)
US Patent
CV6 Therapeutics (NI)
US Patent
Affinity DataIC50: 2.00E+3nMAssay Description:The assay employs a DNA polymerase-based approach utilizing an oligonucleotide template with 3 distinct regions: a 3′ primer binding region, a ...More data for this Ligand-Target Pair
TargetDeoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial(Homo sapiens (Human))
CV6 Therapeutics (NI)
US Patent
CV6 Therapeutics (NI)
US Patent
Affinity DataIC50: 2.00E+3nMAssay Description:The assay employs a DNA polymerase-based approach utilizing an oligonucleotide template with 3 distinct regions: a 3′ primer binding region, a ...More data for this Ligand-Target Pair
TargetDeoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial(Homo sapiens (Human))
CV6 Therapeutics (NI)
US Patent
CV6 Therapeutics (NI)
US Patent
Affinity DataIC50: 2.50E+3nMAssay Description:The assay employs a DNA polymerase-based approach utilizing an oligonucleotide template with 3 distinct regions: a 3′ primer binding region, a ...More data for this Ligand-Target Pair
TargetDeoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial(Homo sapiens (Human))
CV6 Therapeutics (NI)
US Patent
CV6 Therapeutics (NI)
US Patent
Affinity DataIC50: 3.00E+3nMAssay Description:The assay employs a DNA polymerase-based approach utilizing an oligonucleotide template with 3 distinct regions: a 3′ primer binding region, a ...More data for this Ligand-Target Pair
TargetDeoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial(Homo sapiens (Human))
CV6 Therapeutics (NI)
US Patent
CV6 Therapeutics (NI)
US Patent
Affinity DataIC50: 3.00E+3nMAssay Description:The assay employs a DNA polymerase-based approach utilizing an oligonucleotide template with 3 distinct regions: a 3′ primer binding region, a ...More data for this Ligand-Target Pair
TargetDeoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial(Homo sapiens (Human))
CV6 Therapeutics (NI)
US Patent
CV6 Therapeutics (NI)
US Patent
Affinity DataIC50: 3.75E+3nMAssay Description:The assay employs a DNA polymerase-based approach utilizing an oligonucleotide template with 3 distinct regions: a 3′ primer binding region, a ...More data for this Ligand-Target Pair
TargetDeoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial(Homo sapiens (Human))
CV6 Therapeutics (NI)
US Patent
CV6 Therapeutics (NI)
US Patent
Affinity DataIC50: 4.00E+3nMAssay Description:The assay employs a DNA polymerase-based approach utilizing an oligonucleotide template with 3 distinct regions: a 3′ primer binding region, a ...More data for this Ligand-Target Pair
TargetDeoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial(Homo sapiens (Human))
CV6 Therapeutics (NI)
US Patent
CV6 Therapeutics (NI)
US Patent
Affinity DataIC50: 6.25E+3nMAssay Description:The assay employs a DNA polymerase-based approach utilizing an oligonucleotide template with 3 distinct regions: a 3′ primer binding region, a ...More data for this Ligand-Target Pair
TargetDeoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial(Homo sapiens (Human))
CV6 Therapeutics (NI)
US Patent
CV6 Therapeutics (NI)
US Patent
Affinity DataIC50: 1.40E+4nMAssay Description:The assay employs a DNA polymerase-based approach utilizing an oligonucleotide template with 3 distinct regions: a 3′ primer binding region, a ...More data for this Ligand-Target Pair
TargetDeoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial(Homo sapiens (Human))
CV6 Therapeutics (NI)
US Patent
CV6 Therapeutics (NI)
US Patent
Affinity DataIC50: 2.00E+4nMAssay Description:The assay employs a DNA polymerase-based approach utilizing an oligonucleotide template with 3 distinct regions: a 3′ primer binding region, a ...More data for this Ligand-Target Pair
TargetDeoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial(Homo sapiens (Human))
CV6 Therapeutics (NI)
US Patent
CV6 Therapeutics (NI)
US Patent
Affinity DataIC50: >2.50E+4nMAssay Description:The assay employs a DNA polymerase-based approach utilizing an oligonucleotide template with 3 distinct regions: a 3′ primer binding region, a ...More data for this Ligand-Target Pair
TargetDeoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial(Homo sapiens (Human))
CV6 Therapeutics (NI)
US Patent
CV6 Therapeutics (NI)
US Patent
Affinity DataIC50: >2.50E+4nMAssay Description:The assay employs a DNA polymerase-based approach utilizing an oligonucleotide template with 3 distinct regions: a 3′ primer binding region, a ...More data for this Ligand-Target Pair
TargetDeoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial(Homo sapiens (Human))
CV6 Therapeutics (NI)
US Patent
CV6 Therapeutics (NI)
US Patent
Affinity DataIC50: 1.50E+5nMAssay Description:The assay employs a DNA polymerase-based approach utilizing an oligonucleotide template with 3 distinct regions: a 3′ primer binding region, a ...More data for this Ligand-Target Pair
TargetDeoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial(Homo sapiens (Human))
CV6 Therapeutics (NI)
US Patent
CV6 Therapeutics (NI)
US Patent
Affinity DataIC50: 1.50E+5nMAssay Description:The assay employs a DNA polymerase-based approach utilizing an oligonucleotide template with 3 distinct regions: a 3′ primer binding region, a ...More data for this Ligand-Target Pair
TargetDeoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial(Homo sapiens (Human))
CV6 Therapeutics (NI)
US Patent
CV6 Therapeutics (NI)
US Patent
Affinity DataIC50: 1.50E+5nMAssay Description:The assay employs a DNA polymerase-based approach utilizing an oligonucleotide template with 3 distinct regions: a 3′ primer binding region, a ...More data for this Ligand-Target Pair
